Timing of the hepatic arterial phase during contrast-enhanced computed tomography of the liver -: Assessment of normal values in 25 volunteers

被引:28
作者
Bader, TR [1 ]
Prokesch, RW [1 ]
Grabenwöger, F [1 ]
机构
[1] Univ Vienna, Dept Radiol, A-1090 Vienna, Austria
关键词
liver; CT; helical CT; contrast media; contrast enhancement; blood; flow dynamics;
D O I
10.1097/00004424-200008000-00005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVES. TO define normal values of the beginning and duration of the hepatic arterial phase (HAP) during contrast-enhanced computed tomography (CT), METHODS. Twenty-five volunteers (16 men, 9 women; mean age, 60.0 years) without history or suspicion of liver disease were examined with dynamic single-section CT. Scanning was performed at a single level that included the liver, aorta, and portal vein. A series of 25 scans was obtained over a period of 88 seconds (1 baseline scan followed by 16 scans every 2 seconds and 8 scans every 7 seconds) beginning with the injection of a bolus of contrast agent (40 mt, 10 mL/s) and a 40-mL NaCl bolus chaser. Contrast enhancement in the liver, aorta, and portal vein was measured with regions of interest, and time-density curves were obtained. These data were processed with a pharmacodynamic fitting program and the duration of the HAP was calculated. The onsets of the HAP and the portal venous phase were assessed as lag times, referring to the beginning of enhancement in the abdominal aorta. RESULTS. The mean lag time of the HAP was 5.4 seconds after the aorta and the mean duration was 8.6 seconds, The mean lag time of the portal venous phase was 13.9 seconds after the aorta. CONCLUSIONS. These data can be used to optimize protocols for routine CT, Because of the short duration of the HAP, imaging of the entire liver during this phase Is possible only with multidetector CT scanners.
引用
收藏
页码:486 / 492
页数:7
相关论文
共 30 条
[1]   Aortic and hepatic contrast medium enhancement at CT part II. Effect of reduced cardiac output in a porcine model [J].
Bae, KT ;
Heiken, JP ;
Brink, JA .
RADIOLOGY, 1998, 207 (03) :657-662
[2]   Aortic and hepatic contrast medium enhancement at CT part I. Prediction with a computer model [J].
Bae, KT ;
Heiken, JP ;
Brink, JA .
RADIOLOGY, 1998, 207 (03) :647-655
[3]  
Baron Richard L., 1997, Rays (Rome), V22, P270
[4]   UNDERSTANDING AND OPTIMIZING USE OF CONTRAST MATERIAL FOR CT OF THE LIVER [J].
BARON, RL .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 163 (02) :323-331
[5]  
Blomley JK, 1997, BRIT J RADIOL, V70, P351
[6]   HEPATIC CT ENHANCEMENT .2. ALTERATIONS IN CONTRAST MATERIAL VOLUME AND RATE OF INJECTION WITHIN THE SAME PATIENTS [J].
CHAMBERS, TP ;
BARON, RL ;
LUSH, RM .
RADIOLOGY, 1994, 193 (02) :518-522
[7]   BOLUS GEOMETRY AND DYNAMICS AFTER INTRAVENOUS CONTRAST-MEDIUM INJECTION [J].
CLAUSSEN, CD ;
BANZER, D ;
PFRETZSCHNER, C ;
KALENDER, WA ;
SCHORNER, W .
RADIOLOGY, 1984, 153 (02) :365-368
[8]   Effect of rate of contrast medium injection on hepatic enhancement at CT [J].
Garcia, PA ;
Bonaldi, VM ;
Bret, PM ;
Liang, LJ ;
Reinhold, C ;
Atri, M .
RADIOLOGY, 1996, 199 (01) :185-189
[9]   DYNAMIC INCREMENTAL CT - EFFECT OF VOLUME AND CONCENTRATION OF CONTRAST MATERIAL AND PATIENT WEIGHT ON HEPATIC ENHANCEMENT [J].
HEIKEN, JP ;
BRINK, JA ;
MCCLENNAN, BL ;
SAGEL, SS ;
CROWE, TM ;
GAINES, MV .
RADIOLOGY, 1995, 195 (02) :353-357
[10]  
HEINZEL G, 1995, OPFIT 2 0 PHARMACOKI